DUBLIN, March 31, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on ...

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer ACCESS Newswire·Sunshine Biopharma Inc.

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”) is pleased to announce that it has closed ...

Reports Q4 revenue $1.58M, consensus $1.7M. “During 2024 and Q1 2025, we made significant progress shaping the company for success,” said Daniel Passeri, chief executive officer of Cue ...

Novo is paying up to $1 billion for a “non-incretin” medicine that might boost Wegovy’s effects. Elsewhere, Arbutus laid off 57% of its workforce and Bicycle Therapeutics shook up its leadership team.

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

The finalists for the biopharma track of INVEST Pitch Perfect have been selected. At the INVEST Pitch Perfect boutique healthcare investor conference, six biopharma companies will present their ...

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals.

(KRON) — A Bay Area biotech company is laying off half of its staff amid what it is calling a “strategic portfolio review.” Sutro Biopharma is cutting 65 jobs across two Bay Area locations.

On Tuesday, Bernstein released a report detailing the complexities of tariff risks within the biopharma sector and its potential impact on major companies. The analysis aims to unravel the ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting for nearly a third of those rounds. The cuts were accompanied by eight ...

Sutro Biopharma is undergoing a seismic shake-up—jettisoning its CEO, half of its workforce, its lead candidate and its manufacturing facility in a major bid to save cash. The almost 50% layoffs ...